Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
Authors:
- Wataru YamagamiWYWataru Yamagami
- Mikio MikamiMMMikio Mikami
- Satoru NagaseSNSatoru Nagase
- Tsutomu TabataTTTsutomu Tabata
- Yoichi KobayashiYKYoichi Kobayashi
- Masanori KaneuchiMKMasanori Kaneuchi
- Hiroaki KobayashiHKHiroaki Kobayashi
- Hidekazu YamadaHYHidekazu Yamada
- Kiyoshi HasegawaKHKiyoshi Hasegawa
- Hiroyuki FujiwaraHFHiroyuki Fujiwara
- Hidetaka KatabuchiHKHidetaka Katabuchi
- Daisuke AokiDADaisuke Aoki
Open Access
- 1 January 2020
- journal article
- research article
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 31 (1) , e18
Abstract
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for endometrial cancer, 3. Postoperative adjuvant therapy for endometrial cancer, 4. Post-treatment surveillance for endometrial cancer, 5. Treatment for advanced or recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment of uterine carcinosarcoma and uterine sarcoma, 8. Treatment of trophoblastic disease, 9. Document collection; and nine algorithms: 1-3. Initial treatment of endometrial cancer, 4. Postoperative adjuvant treatment for endometrial cancer, 5. Treatment of recurrent endometrial cancer, 6. Fertility-sparing therapy, 7. Treatment for uterine carcinosarcoma, 8. Treatment for uterine sarcoma, 9. Treatment for choriocarcinoma. Each chapter includes overviews and clinical questions, and recommendations, objectives, explanation, and references are provided for each clinical question. This revision has no major changes compared to the 3rd edition, but does have some differences: 1) an explanation of the recommendation decision process and conflict of interest considerations have been added in the overview, 2) nurses, pharmacists and patients participated in creation of the guidelines, in addition to physicians, 3) the approach to evidence collection is listed at the end of the guidelines, and 4) for clinical questions that lack evidence or clinical validation, the opinion of the Guidelines Committee is given as a "Recommendations for tomorrow".Keywords
This publication has 5 references indexed in Scilit:
- Clinical statistics of gynecologic cancers in JapanJournal of Gynecologic Oncology, 2017
- Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasmsInternational Journal of Clinical Oncology, 2016
- Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 editionInternational Journal of Clinical Oncology, 2010
- [Guidelines for proper use of antineoplastic agents. Gynecologic cancer].2002
- [Guideline for correct use of antineoplastic agents (draft). General theory].2002